Sanara Medtech Inc is a reputable company known for its strong values and corporate philosophy. With a customer-centric approach, they prioritize innovation, excellence, and integrity in all their operations. Sanara Medtech Inc aims to provide cutting-edge medical technologies and solutions that improve patient outcomes and quality of life. Backed by a highly skilled team and state-of-the-art research, they strive to deliver superior healthcare products and services. By fostering partnerships and collaboration, Sanara Medtech Inc demonstrates a commitment to advancing medical advancements and driving positive change in the industry. Their dedication to promoting excellence and integrity sets them apart as a leader in the healthcare sector.

Sanara Medtech Inc is primarily present in the United States.

Sanara Medtech Inc has achieved several significant milestones. The company successfully developed and commercialized its flagship product, the BIAKŌS® Antimicrobial Barrier Film, which provides advanced wound care solutions. Sanara Medtech Inc also received FDA 510(k) clearance for its BIAKŌS® Wound Gel, expanding its product portfolio. Additionally, the company formed strategic partnerships with healthcare providers and established distribution agreements to enhance market reach. Sanara Medtech Inc's dedication to innovation, regulatory compliance, and customer satisfaction has solidified its position as a leader in the medical technology industry.

Sanara Medtech Inc, formerly known as Wound Management Technologies, is a Texas-based medical technology company. It specializes in developing and commercializing advanced wound care products. Established in 2014, Sanara Medtech focuses on delivering innovative solutions to address acute and chronic wounds. Their products include a range of advanced wound dressings, collagen-based dressings, and therapeutic lotions designed to promote healing and improve patient outcomes. With a dedicated team of experts and strong research and development capabilities, Sanara Medtech is committed to providing effective and reliable wound care solutions to patients and healthcare providers worldwide.

The main competitors of Sanara Medtech Inc in the market include companies such as Acelity, Mölnlycke Health Care, and Smith & Nephew.

Sanara Medtech Inc is primarily active in the medical technology industry.

The business model of Sanara Medtech Inc focuses on developing and commercializing innovative biotechnology and medical device products. The company aims to provide advanced wound care solutions to cater to the growing needs of patients worldwide. Sanara Medtech Inc leverages its expertise in wound healing and tissue regeneration to develop cutting-edge products that enhance patient outcomes. By offering a diverse portfolio of advanced products, the company aims to address the unmet needs of healthcare professionals and improve the quality of life for patients. Sanara Medtech Inc continually strives to expand its market presence and deliver innovative solutions for wound healing and tissue repair.

Raportul Sanara Medtech preț/beneficiu este -15,23.

Raportul Sanara Medtech preț/vânzări este 3,34.

Scorul de calitate AlleAktien pentru Sanara Medtech este 4/10.

Cifra de afaceri a așteptată Sanara Medtech este de 82,52 milioane USD.

Profitul așteptată Sanara Medtech este -18,12 milioane USD.

Sanara Medtech Inc. is a leading company in the field of wound care and offers innovative products and solutions for wound healing. The company is headquartered in Dallas, Texas and was founded in 2014. It specializes in providing patients and medical professionals with new products and technologies with clinically proven results. Sanara Medtech operates in three main areas: wound healing, incontinence and hygiene products, and hernia care. In the field of wound healing, the company offers a range of products specifically designed to accelerate and improve wound healing. This is achieved through the use of innovative dressing systems that regulate moisture, temperature, and oxygen levels to achieve optimal healing outcomes. In the incontinence and hygiene products sector, Sanara Medtech provides bladder and bowel incontinence management. Special absorbent pads and underpads are provided that are suitable for both men and women. The company also offers effective and skin-friendly cleansing lotions and cleaning products. In the hernia care sector, the company offers various implants and meshes. These include both new developments and standard products used for the stabilization of abdominal wall hernias. The products are surgical instruments and medical devices manufactured to the highest quality standards to achieve the best possible benefit for patients. Sanara Medtech's business model is focused on the healthcare market and aims to provide the best customer service and products in the field of wound care and medical devices. To achieve this, the company works closely with medical professionals and patient organizations. Sanara Medtech is committed to continuously improving existing products and offering innovative solutions in wound care to provide the best possible benefit for patients. Innovation, quality, and customer service are the key elements of Sanara Medtech's business model. The company relies on effective organization and coordination of all business areas, from research and development to sales. Sanara Medtech also aims to ensure sustainable economic growth through appropriate measures. In summary, Sanara Medtech Inc. is a company operating in the fields of wound healing, incontinence and hygiene products, and hernia care. The company offers innovative products and solutions of the highest quality standard and is committed to achieving the best possible benefit for patients through continuous research and development. The close partnerships with medical professionals and patient organizations enable the company to develop innovative products and provide the best possible customer service.

Sanara Medtech distribuie un dividend de 0 USD în plăți anuale.

Dividenda nu poate fi calculată în prezent pentru Sanara Medtech sau compania nu distribuie dividende.

Codul ISIN pentru Sanara Medtech este US79957L1008.

Ticker-ul pentru Sanara Medtech este SMTI.

În ultimele 12 luni, Sanara Medtech a plătit un dividend în valoare de . Aceasta corespunde unei randamente a dividendului de aproximativ . Pentru următoarele 12 luni, Sanara Medtech va plăti probabil un dividend de 0 USD.

Randamentul dividendelor pentru Sanara Medtech este în prezent de .

Sanara Medtech plătește un dividend trimestrial. Acesta este distribuit în lunile .

Sanara Medtech a plătit dividende în fiecare an, în ultimii 0 ani.

Pentru următoarele 12 luni se așteaptă dividende în valoare de 0 USD. Acest lucru corespunde unei randamente a dividendelor de 0 %.

Sanara Medtech este atribuit sectorului 'Sănătate'.

Pentru a primi ultimul dividend de Sanara Medtech de la 11.09.2024 în valoare de 0 USD, trebuia să deții acțiunea în portofoliu înainte de ziua Ex-Tag de pe 11.09.2024.

Ultima plată a dividendului a fost efectuată la 11.09.2024.

În anul 2023, Sanara Medtech a distribuit 0 USD sub formă de dividende.

Dividendele de la Sanara Medtech sunt distribuite în USD.